1 clip
a16z Podcast · Vasant Narasimhan
Novartis CEO explains the harsh reality behind AI drug discovery hype - while everyone expects breakthrough results in two years, the first purely AI-generated drug candidate won't emerge for 8-10 years. He shares how Novartis is partnering with Isomorphic Labs to tackle previously 'undruggable' targets using AlphaFold technology.